Twist Bioscience's Series E Round

Twist Bioscience raised a round of funding on March 27, 2017.

Twist Bioscience is a biotechnology company offering synthetic DNA production for specialty chemical compounds and drug development. By synthesizing DNA on silicon instead of on traditional 96-well pl…

Articles about Twist Bioscience's Series E Round: